Daniel H. Tsai

St George's University Of London
London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 31 publications

Methodological considerations of suicide risk following antipsychotic therapy in treatment-resistant depression.

Methodological considerations of suicide risk following antipsychotic therapy in treatment-resistant depression.

Journal: The British journal of psychiatry : the journal of mental science

Published: June 25, 2026

Real-world safety of aflibercept 8 mg in neovascular age-related macular degeneration.

Real-world safety of aflibercept 8 mg in neovascular age-related macular degeneration.

Journal: Naunyn-Schmiedeberg's archives of pharmacology

Published: May 29, 2026

Association Between Pneumonia Risk and Anticholinergic Burden Among Patients with Different Frailty Levels [Response to Letter].

Association Between Pneumonia Risk and Anticholinergic Burden Among Patients with Different Frailty Levels [Response to Letter].

Journal: Clinical epidemiology

Published: March 17, 2026

Intraocular inflammation incidence and real-world safety of intravitreal faricimab treatment across retinal indications.

Intraocular inflammation incidence and real-world safety of intravitreal faricimab treatment across retinal indications.

Journal: Naunyn-Schmiedeberg's archives of pharmacology

Published: December 02, 2025

Trends in First-Line Glaucoma Treatment from 2013 to 2024: A Multi-institutional and Multinational Cohort Study.

Trends in First-Line Glaucoma Treatment from 2013 to 2024: A Multi-institutional and Multinational Cohort Study.

Journal: Ophthalmology and therapy

Published: October 13, 2025

SGLT-2 Inhibitor use and liver-related and mortality outcomes in patients with type 2 diabetes and compensated cirrhosis.

SGLT-2 Inhibitor use and liver-related and mortality outcomes in patients with type 2 diabetes and compensated cirrhosis.

Journal: BMC medicine

Published: September 26, 2025

Hyperuricemia risk in bempedoic acid-treated hyperlipidemic patients.

Hyperuricemia risk in bempedoic acid-treated hyperlipidemic patients.

Journal: Communications medicine

Published: August 21, 2025

SGLT2 inhibitors, GLP-1 RAs, and DPP4 inhibitors and the risk of hypomagnesemia in type 2 diabetes: A target trial emulation.

SGLT2 inhibitors, GLP-1 RAs, and DPP4 inhibitors and the risk of hypomagnesemia in type 2 diabetes: A target trial emulation.

Journal: PLoS medicine

Published: August 08, 2025

Comparative Effectiveness of Clopidogrel vs. Potent P2Y12 Inhibitors in CYP2C19 Normal Metabolizers Following Percutaneous Coronary Intervention: A Real-World Cohort Study.

Comparative Effectiveness of Clopidogrel vs. Potent P2Y12 Inhibitors in CYP2C19 Normal Metabolizers Following Percutaneous Coronary Intervention: A Real-World Cohort Study.

Journal: British journal of clinical pharmacology

Published: August 07, 2025

Taiwan's National Health Insurance Research Database (NHIRD): in the Era of Artificial Intelligence, Causal Inference, and Data Security.

Taiwan's National Health Insurance Research Database (NHIRD): in the Era of Artificial Intelligence, Causal Inference, and Data Security.

Journal: Clinical epidemiology

Published: July 28, 2025

Sodium-Glucose Cotransporter 2 Inhibitors Prevent Nephrolithiasis in Patients with Diabetes: A TriNetX-Based Real-World Global Comparison.

Sodium-Glucose Cotransporter 2 Inhibitors Prevent Nephrolithiasis in Patients with Diabetes: A TriNetX-Based Real-World Global Comparison.

Journal: Kidney360

Published: June 28, 2025

Global, Regional, and National Burden of Nontraumatic Subarachnoid Hemorrhage: The Global Burden of Disease Study 2021.

Global, Regional, and National Burden of Nontraumatic Subarachnoid Hemorrhage: The Global Burden of Disease Study 2021.

Journal: JAMA neurology

Published: May 23, 2025

Showing 1-12 of 31

Last Updated: 09/26/2026